Rachael Rowswell-Turner, Ph.D.
Affiliations: | 2011 | Microbiology and Immunology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
ImmunologyGoogle:
"Rachael Rowswell-Turner"Parents
Sign in to add mentor| Nejat Egilmez | grad student | 2011 | SUNY Buffalo | |
| (Chronic Chemoimmunotherapy Achieves Cure of Advanced Spontaneous Mammary Tumors via Persistent Blockade of Post-Therapy Counter-Regulation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rowswell-Turner RB, Singh RK, Urh A, et al. (2021) HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression. Journal of Immunology (Baltimore, Md. : 1950) |
| James NE, Emerson JB, Borgstadt AD, et al. (2020) The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes. Scientific Reports. 10: 8558 |
| James NE, Oliver MT, Ribeiro JR, et al. (2019) Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6. Frontiers in Pharmacology. 10: 216 |
| James NE, Cantillo E, Oliver MT, et al. (2018) HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells. Clinical and Experimental Immunology |
| Egilmez NK, Harden JL, Rowswell-Turner RB. (2012) Chemoimmunotherapy as long-term maintenance therapy for cancer. Oncoimmunology. 1: 563-565 |
| Rowswell-Turner RB, Harden JL, Nair RE, et al. (2011) Chronic chemoimmunotherapy achieves cure of spontaneous murine mammary tumors via persistent blockade of posttherapy counter-regulation. Journal of Immunology (Baltimore, Md. : 1950). 187: 4109-18 |
| Harden JL, Gu T, Kilinc MO, et al. (2011) Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. Journal of Immunology (Baltimore, Md. : 1950). 187: 126-32 |
| Gu T, Rowswell-Turner RB, Kilinc MO, et al. (2010) Central role of IFNgamma-indoleamine 2,3-dioxygenase axis in regulation of interleukin-12-mediated antitumor immunity. Cancer Research. 70: 129-38 |
| Kilinc MO, Rowswell-Turner RB, Gu T, et al. (2009) Activated CD8+ T-effector/memory cells eliminate CD4+ CD25+ Foxp3+ T-suppressor cells from tumors via FasL mediated apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 183: 7656-60 |